Mode of Action, and In Vitro and In Vivo Activities of the Fluoroquinolones
- 1 February 1988
- journal article
- review article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 28 (2) , 156-168
- https://doi.org/10.1002/j.1552-4604.1988.tb05967.x
Abstract
No abstract availableThis publication has 84 references indexed in Scilit:
- The frequency of in-vitro resistance development to fluoroquinolones and the use of a murine pyelonephritis model to demonstrate selection of resistance in vivoJournal of Antimicrobial Chemotherapy, 1987
- The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of Gram-negative rods and staphylococci isolated from infected hospitalised patientsJournal of Antimicrobial Chemotherapy, 1986
- Effect of ciprofloxacin on phagocytosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1985
- Low frequency of bacterial resistance to enoxacin in vitro and in experimental pneumoniaJournal of Antimicrobial Chemotherapy, 1985
- In vitro activity of amifloxacin againstChlamydia trachomatis andUreaplasma urealyticumEuropean Journal of Clinical Microbiology & Infectious Diseases, 1985
- Incomplete Cross-Resistance of Nalidixic and Pipemidic Acid-Resistant Variants of Serratia marcescens Against Ciprofloxacin, Enoxacin, and NorfloxacinChemotherapy, 1985
- Mutational resistance to 4-quinolone antibacterial agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Intraphagocytic Bactericidal Activity of Bacterial DNA Gyrase Inhibitors against Serratia marcescensChemotherapy, 1984
- In vitro emergence ofEscherichia coli andPseudomonas aeruginosa strains resistant to norfloxacin and nalidixic acidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- In vitro activity of norfloxacin againstMycoplasma hominis andUreaplasma urealyticumEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983